ETAMSYLATE

Etamsylate strengthens capillary walls and improves platelet function to reduce bleeding. Side effects include rash, GI upset, and headache.

SKU: f93181d1beca Category: Tag:

Product Description


Mechanism of Action

Etamsylate is a hemostatic agent that enhances platelet adhesiveness, stabilizes capillary endothelial junctions and reduces abnormal capillary bleeding. Its mechanism is linked to modulation of prostaglandin synthesis and improved microvascular stability.

Benefits and Advantages

Used in microcirculation‑research, platelet‑function studies, capillary‑fragility modelling, and perioperative hemostasis assays.

Side Effects and Risks

Risks include headache, nausea, rash and rare thrombosis. Handle with vascular‑active hemostatic‑agent precautions.

Datasheet


Molecular Formula

C10H17NO5S

Molecular Weight

263.31 g/mol

CAS Number

2624-44-4

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Etamsylate; ETHAMSYLATE; 2624-44-4; Cyclonamine; Dicynene

IUPAC/Chemical Name

2,5-dihydroxybenzenesulfonic acid;N-ethylethanamine

InChl Key

HBGOLJKPSFNJSD-UHFFFAOYSA-N

InChl Code

InChI=1S/C6H6O5S.C4H11N/c7-4-1-2-5(8)6(3-4)12(9,10)11;1-3-5-4-2/h1-3,7-8H,(H,9,10,11);5H,3-4H2,1-2H3

References

https://pubchem.ncbi.nlm.nih.gov/compound/17506;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download